| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/31/2006 | EP1661997A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/31/2006 | EP1661996A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/31/2006 | EP1661995A1 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 05/31/2006 | EP1661994A1 Therapeutic agent for NGF |
| 05/31/2006 | EP1661993A1 SLY1 inhibitors in organ, tissue and cell transplantation |
| 05/31/2006 | EP1661915A1 Preparation of antibodies against the human chitinase-like protein GL008 |
| 05/31/2006 | EP1660970A2 Systems and methods for biopolymer engineering |
| 05/31/2006 | EP1660664A1 Poxvirus vector encoding prostate specific antigens for treatment of prostate cancer |
| 05/31/2006 | EP1660655A2 Look-through mutagenesis |
| 05/31/2006 | EP1660654A1 Expression vector |
| 05/31/2006 | EP1660638A2 Lipoparticles comprising proteins, methods of making, and using the same |
| 05/31/2006 | EP1660538A1 Anti-lewis y anti-idiotypic antibodies and uses thereof |
| 05/31/2006 | EP1660537A2 Endotheliase-2 ligands |
| 05/31/2006 | EP1660536A2 FACTOR IXa SPECIFIC ANTIBODIES DISPLAYING FACTOR VIIIa LIKE ACTIVITY |
| 05/31/2006 | EP1660535A2 Techniques and compositions for the diagnosis and treatment of cancer (muc1) |
| 05/31/2006 | EP1660534A2 Humanization of antibodies |
| 05/31/2006 | EP1660533A2 Monoclonal antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence |
| 05/31/2006 | EP1660519A2 Fluorinated carbohydrate conjugates |
| 05/31/2006 | EP1660517A2 Nogo receptor antagonists |
| 05/31/2006 | EP1660514A2 A novel gene and protein associated with angiogenesis and endothelial apoptosis |
| 05/31/2006 | EP1660513A2 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 05/31/2006 | EP1660186A2 Humanization of antibodies |
| 05/31/2006 | EP1660136A2 Trefoil factor 3 (tff3) as a target for anti-cancer therapy |
| 05/31/2006 | EP1660135A1 Method of treating hepatocellular carcinoma |
| 05/31/2006 | EP1660129A2 Anti-cd20 therapy of ocular disorders |
| 05/31/2006 | EP1660128A2 Anti-fcrn antibodies for treatment of auto/allo immune conditions |
| 05/31/2006 | EP1660127A1 Antibodies to c-met |
| 05/31/2006 | EP1660126A1 Agonists or antagonists of the clucocorticoid-induced tumour necrosis factor receptor (gitr) or its ligand for the treatment of immune disorders, infections and cancer |
| 05/31/2006 | EP1660014A2 Rage-related methods and compositions for treating glomerular injury |
| 05/31/2006 | EP1660010A2 Compositions and methods for restoring sensitivity to treatment with her2 antagonists |
| 05/31/2006 | EP1659918A2 Antibodies directed to parathyroid hormone (pth) and uses thereof |
| 05/31/2006 | EP1604032A4 Method for detecting prognosis of cancer |
| 05/31/2006 | EP1576012A4 Monoclonal antibody against asialo alpha 1-acid glycoprotein, immunochromatographic strip comprising the monoclonal antibody, and method for diagnosing liver diseases using the immunochromatographic strip |
| 05/31/2006 | EP1499642A4 Dna dependent protein kinase catalytic subunit phosphorylation sites and antibodies thereto |
| 05/31/2006 | EP1313855B1 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 05/31/2006 | EP1268798B1 Anti-angiogenic properties of vascostatin and fragments or variants thereof |
| 05/31/2006 | EP1248641B1 Use of emap ii receptor antagonist composition for treating pulmonary hypertension |
| 05/31/2006 | EP1231270B1 Novel protein and dna thereof |
| 05/31/2006 | EP1169645B1 Methods and compositions for diagnosing carcinomas |
| 05/31/2006 | EP1165110B1 Antagonists of hmg1 for treating inflammatory conditions |
| 05/31/2006 | EP1115426B1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 05/31/2006 | EP1108014B1 Ehrlichia canis protein |
| 05/31/2006 | EP1073682B1 Heparanase specific molecular probes and their use in research and medical applications |
| 05/31/2006 | EP1045027B1 Novel gene having reverse transcriptase motif |
| 05/31/2006 | EP0974671B1 Method for diagnosing bone dysbolism |
| 05/31/2006 | EP0914437B1 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin |
| 05/31/2006 | EP0911342B1 Novel protein and process for producing the same |
| 05/31/2006 | EP0840789B1 Transketolase-related protein |
| 05/31/2006 | EP0791076B1 Diagnostic method and kit for determining kell blood group genotype |
| 05/31/2006 | CN1781023A Gastrin hormone immunoassays |
| 05/31/2006 | CN1780922A Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) |
| 05/31/2006 | CN1780911A Human antihuman interleukin-18 antibody, fragment thereof and method of using the same |
| 05/31/2006 | CN1780907A Anti-CCR5 antibody |
| 05/31/2006 | CN1780905A Process for the production of biological substances by perfusion culturing of suspended animal cells |
| 05/31/2006 | CN1780856A Human antibodies specific for interleukin 15 (IL-15) |
| 05/31/2006 | CN1780855A Human IL-1 beta antagonists |
| 05/31/2006 | CN1780641A Single chain antigen-binding polypeptides for polymer conjugation |
| 05/31/2006 | CN1780607A Zinc-containing sustained-release composition, its preparation, and method for producing the same |
| 05/31/2006 | CN1778922A Variable area gene for single-clone antibody of anti-tumour necrotized factor with high neutralizing activity and preparation thereof |
| 05/31/2006 | CN1778921A Variable area gene for single-clone antibody of anti-tumour necrotized factor with high neutralizing activity and preparation thereof |
| 05/31/2006 | CN1778822A Monoclonal antibody of C-shaped agglutinin receptor L1, its production and use thereof |
| 05/31/2006 | CN1778816A Human cell surface membrane molecule and use thereof |
| 05/31/2006 | CN1257976C Improved vaccines |
| 05/30/2006 | US7053202 Immunoglobulin DNA cassette molecules, monobody constructs, methods of production, and methods of use therefor |
| 05/30/2006 | US7053190 Antibody for use in the treatment and diagnosis of immunological and lysomal defect |
| 05/30/2006 | US7053189 Human dopamine receptor and its uses |
| 05/30/2006 | US7053188 Diagnosis of cancer tissue; monoclonal antibodies |
| 05/30/2006 | US7053187 Sperm-specific monoclonal antibody, mAbC |
| 05/30/2006 | US7053186 Protein for use in diagnosis and treatment of cancer |
| 05/30/2006 | US7053184 Expression vector coding polypeptide with thrombin proteolytic sequences; for use in evaluating ligand binding and signal transduction |
| 05/30/2006 | US7053183 Human cyclic nucleotide-gated cation channel polypeptide |
| 05/30/2006 | US7053182 for transgenic plants |
| 05/30/2006 | US7053045 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 05/30/2006 | US7052892 For preventing, ameliorating, disorders or diseases including cancer, peripheral and central nervous system disorders, genitourinary disorders, cardiovascular disorders, and Chronic obstructive pulmonary (or airways) disease (COPD) |
| 05/30/2006 | US7052890 Transglutaminase gene products |
| 05/30/2006 | US7052889 Mammalian SUV39H2 proteins and isolated DNA molecules encoding them |
| 05/30/2006 | US7052873 Natural human antibody |
| 05/30/2006 | US7052872 Bi-specific antibodies for pre-targeting diagnosis and therapy |
| 05/30/2006 | US7052862 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 05/30/2006 | US7052861 Graphitic nanotubes in luminescence assays |
| 05/30/2006 | US7052860 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 05/30/2006 | US7052859 MUCIN 4 expression as a marker for pancreatic cancer |
| 05/30/2006 | US7052855 Using apolipoprotein specific immunoglobulin to diagnosis and treat arteriosclerosis, hyperlipidemia and cardiovascular disorders |
| 05/30/2006 | US7052849 Antibody for use in the diagnosis of diabetic disorders |
| 05/30/2006 | US7052830 diagnosing infection by way of binding an antibody or antigen reading frame then translating open; vaccines |
| 05/30/2006 | US7052703 T-cell receptorγ alternate reading frame protein, (TARP) and uses thereof |
| 05/30/2006 | US7052694 Immunoglobulin which specifically binds cell surface protein of nervous system tissue for preventing infections and treating tumors; anticarcinogenic agents; bactericides |
| 05/30/2006 | US7052693 Anti-human VEGF receptor FLT-1 monoclonal antibody |
| 05/30/2006 | US7052689 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/30/2006 | US7052676 Interference with binding chemokines |
| 05/30/2006 | US7052675 binding antibody to substrate; neutralization of infection prions; in vivo diagnosis testing |
| 05/30/2006 | US7052674 Prokineticin polypeptides, related compositions and methods |
| 05/30/2006 | CA2242767C Glycosidase enzymes |
| 05/26/2006 | WO2006055809A2 Antibodies against vascular endothelial growth factor receptor-1 |
| 05/26/2006 | WO2006055638A2 Fully human monoclonal antibodies to il-13 |
| 05/26/2006 | WO2006054991A1 Magnetic enrichment of circulating cells, fragments and debris for enabling hts proteomics and genomics in disease detection |
| 05/26/2006 | WO2006054961A2 Novel composition and methods for the treatment of immune related diseases |
| 05/26/2006 | WO2006054876A1 Monoclonal antibody to human tgf-beta induced gene-h3 and use thereof |
| 05/26/2006 | WO2006054807A1 METHOD OF SITE-SPECIFICALLY TRANSFERRING UNNATURAL AMINO ACID INTO PROTEIN WITH THE USE OF MITOCHONDRIAL PROTEIN AND METHOD OF EFFICIENTLY PREPARING tRNA |
| 05/26/2006 | WO2006054770A1 Novel map kinase kinase kinase (mapkkk) |